Saxenda vs Victoza – A Thorough Comparison

Obesity is a growing global health concern that often requires a combination of lifestyle changes and medical treatment. For patients comparing liraglutide-based therapies, Saxenda vs Victoza is an important distinction because the medications contain the same active ingredient but have different approved uses and dosing regimens.

Saxenda and Victoza are two medications that have shown effectiveness in managing obesity and type 2 diabetes, respectively. Both contain the active ingredient liraglutide but are approved for different purposes: Saxenda is used for chronic weight management, while Victoza is primarily prescribed to help control blood sugar levels in individuals with type 2 diabetes.

Medical practices looking to purchase Saxenda wholesale should source the medication through authorized suppliers and follow applicable requirements for prescription medicines, storage, and handling.

This Saxenda vs Victoza comparison explores their approved uses, dosing schedules, effectiveness, and potential side effects to clarify the key differences between the two medications.

Key Takeaways

• Saxenda is for adults who need to lose weight. It controls how much you eat by making you feel full.
• Victoza helps people with type 2 diabetes control their blood sugar levels. Both kids over ten years old and adults can use it.
• The FDA approved Saxenda for weight loss and Victoza for diabetes care. Both use the drug liraglutide but in different ways.
• People using either Saxenda or Victoza might feel sick, have a headache, or get stomach problems like throwing up or diarrhea.
• Studies show Saxenda works well for losing weight. Victoza is good at managing blood sugar in diabetes patients.

About: DoctorMedica is your trusted supplier of top-quality dermal fillers, viscosupplements, and more for your medical practice. We offer genuine products from leading brands at the lowest prices in the market.

Saxenda vs Victoza: Key Differences Between the Medications

Saxenda is a prescription medication for weight management. Its active ingredient is liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Saxenda injections mimic the action of the GLP-1 hormone, which helps regulate appetite and food intake [1]. It is typically prescribed for adults with obesity or overweight individuals with weight-related medical problems.

Saxenda is administered as a daily injection and is part of a comprehensive weight management plan that includes a reduced-calorie diet and increased physical activity.

Victoza, also containing liraglutide, is primarily approved for managing blood sugar levels in individuals with type 2 diabetes. Unlike Saxenda, Victoza is not specifically used for weight loss, although weight reduction can be a beneficial side effect.

Victoza helps control blood glucose by stimulating insulin secretion and slowing gastric emptying, which helps maintain more stable blood sugar levels throughout the day. It is also administered as a daily injection and is often used alongside other diabetes medications to achieve optimal blood sugar control.

FDA Approvals and Target Populations

Saxenda received FDA approval in December 2014 for chronic weight management.

• It is specifically approved for use in adults with a body mass index (BMI) of 30 or greater (obesity) or adults with a BMI of 27 or greater (overweight) who have at least one weight-related condition, such as hypertension, type 2 diabetes, or dyslipidemia.
• Saxenda is also approved for use in adolescents aged 12-17 years with a body weight above 60 kg (132 lbs) and a BMI corresponding to 30 kg/m² or greater for adults.

The FDA approved Victoza in January 2010 for treating type 2 diabetes in adults. It is intended to improve blood sugar control in conjunction with diet and exercise.

• Victoza is also approved for reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
• While not specifically approved for weight loss, Victoza has been observed to aid in weight reduction, which can benefit patients managing type 2 diabetes and obesity.

Dosing Regimens and Effectiveness

When comparing Saxenda vs Victoza, dosing is one of the clearest differences because Saxenda is titrated to a higher maintenance dose for chronic weight management.

Saxenda injections are administered once daily. The dosing regimen starts at 0.6 mg per day for the first week and increases by 0.6 mg each week until the maintenance dose of 3 mg per day is reached [2]. This gradual increase helps minimize gastrointestinal side effects.

Saxenda has been shown to be effective for weight loss. Clinical trials and Saxenda before and after photos indicate that patients using this treatment can lose at least 5% of their starting body weight within 12 weeks of reaching the full 3 mg dose. It mimics the hormone GLP-1, which helps regulate appetite and food intake.

Similarly, Victoza also follows a once-daily injection schedule [3]. It starts at 0.6 mg per day for at least one week to improve gastrointestinal tolerability. The dose is then increased to 1.2 mg per day. If additional glycemic control is needed, the dose can be further increased to a maximum of 1.8 mg per day.

Victoza is effective in managing type 2 diabetes by improving blood sugar control. It stimulates insulin production, slows digestion, and reduces appetite. Clinical studies have shown that Victoza can lower HbA1c levels by 1.0% to 1.5% on average [4]. Additionally, it helps reduce the risk of cardiovascular events in patients with type 2 diabetes.

Side Effects and Safety

Both Saxenda and Victoza, which contain the active ingredient liraglutide, share similar side effects due to their mechanism of action. Common side effects include nausea, vomiting, diarrhea, constipation, and headache. Some patients may also experience decreased appetite, dizziness, and fatigue.

When using Saxenda or Victoza, it’s essential to monitor for signs of serious side effects such as pancreatitis, gallbladder disease, and kidney problems. Both medications should be used with caution in patients with a history of these conditions. Additionally, there is a potential risk of thyroid tumors, including medullary thyroid carcinoma, so they are not recommended for patients with a personal or family history of thyroid cancer. 

Clinical Studies and Outcomes

Saxenda has been extensively studied for its efficacy in weight management. Key clinical trials include the SCALE (Satiety and Clinical Adiposity−Liraglutide Evidence) studies, which evaluated its safety and effectiveness over 56 weeks [5]. These studies demonstrated significant weight loss in participants, with many achieving clinically meaningful reductions in body weight.

Victoza is primarily used for managing type 2 diabetes but has also been studied for weight loss. Clinical trials have shown that Victoza helps lower blood sugar levels and sometimes contributes to weight loss [6]. Studies ranging from 26 to 52 weeks have indicated that Victoza can effectively reduce A1C levels and promote weight loss when combined with other diabetes medications.

The clinical studies for both Saxenda and Victoza have yielded promising results. Saxenda has been shown to help patients achieve and maintain significant weight loss over extended periods. In contrast, Victoza has proven effective in managing blood sugar levels and providing additional weight loss benefits for patients with type 2 diabetes.

Both medications have demonstrated safety and efficacy, making them valuable options for their respective indications.

Conclusion

The Saxenda vs Victoza comparison shows that although both medications contain liraglutide, they are approved for different primary purposes. Saxenda is used for chronic weight management, while Victoza is primarily prescribed for type 2 diabetes management.

Each one is suited to different health goals. So, picking between them depends on what you need: weight control or diabetes management.

FAQs

1. What is the main difference between Saxenda and Victoza?

While similar in composition, Saxenda and Victoza are used for different medical purposes. Victoza aids in controlling blood sugar levels in adults with type 2 diabetes, while Saxenda helps with weight management.

2. Can I use both Saxenda and Victoza together?

Using both medications at once isn’t recommended due to their similarities. It’s best to consult a healthcare professional before changing your medication routine.

3. Are there side effects associated with Saxenda or Victoza?

Yes, like all medications, both can have side effects. Common ones include nausea, headache, and upset stomach, but these usually subside over time.

4. Which one should I choose – Saxenda or Victoza?

The choice between the two depends on your health needs – whether you need help managing diabetes or losing weight. Always discuss this decision with a healthcare provider who knows your history.

Citations

[1] Drugs.com. “Comparing Victoza vs Saxenda.” Drugs.com, n.d., https://www.drugs.com/compare/victoza-vs-saxenda.

[2] Novo Nordisk. “Saxenda® Dosing Schedule.” Saxenda®, n.d., https://www.saxenda.com/about-saxenda/dosing-schedule.html.

[3] Novo Nordisk. “Dosing and Administration: Victoza® (Liraglutide) Injection 1.2 mg or 1.8 mg.” NovoMedLink, n.d., https://www.novomedlink.com/diabetes/products/treatments/victoza/dosing-administration.html.

[4] Pope, Carmen. “Victoza Patient Tips: 7 Things You Should Know.” Drugs.com, updated 9 June 2026, https://www.drugs.com/tips/victoza-patient-tips.

[5] Clinical Trials Arena. “Saxenda (Liraglutide) for the Treatment of Obesity, US.” Clinical Trials Arena, 4 Aug. 2023, https://www.clinicaltrialsarena.com/marketdata/saxenda-liraglutide-obesity/.

[6] Drugs.com. “Will Victoza Help with Weight Loss?” Drugs.com, medically reviewed by Leigh Ann Anderson, updated 13 June 2025, https://www.drugs.com/medical-answers/victoza-weight-loss-3544579/.

[7] Centers for Disease Control and Prevention. “Adult Obesity Facts.” CDC, 14 May 2024, https://www.cdc.gov/obesity/adult-obesity-facts/index.html.

[8] Centers for Disease Control and Prevention. “Consequences of Obesity.” CDC, 9 July 2026, https://www.cdc.gov/obesity/php/about/consequences.html.

[9] U.S. Food and Drug Administration. SAXENDA (Liraglutide [rDNA Origin] Injection): Prescribing Information. Dec. 2014, https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206321Orig1s000lbl.pdf.